Sanbo Brain Hospital, Capital Medical University

Beijing, Beijing Municipality 100093

1 studies enrolling now · 2 studies all time

What they study most

Astrocytoma, Grade IV, Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3, Astrocytoma, IDH-Mutant, Grade 4, Glioblastoma, Glioma, IDH1-mutant Glioma, Oligodendroglioma, Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted

Studies at this site

• SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) — Recruiting now
• A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1 — Completed